Carlos Lumbreras-Bermejo
Overview
Explore the profile of Carlos Lumbreras-Bermejo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez-de-Las-Penas C, Franco-Moreno A, Ruiz-Ruigomez M, Arrieta-Ortubay E, Ryan-Murua P, Lumbreras-Bermejo C, et al.
Viruses
. 2024 Jun;
16(6).
PMID: 38932239
The aim of this study was to investigate the effects of administrating Remdesivir at the acute COVID-19 phase on developing post-COVID symptoms in previously hospitalized COVID-19 survivors by controlling factors...
2.
Pina Belmonte A, Madrazo M, Piles L, Rubio-Rivas M, de Jorge Huerta L, Gomez Antunez M, et al.
Can J Respir Ther
. 2024 Jun;
60:86-94.
PMID: 38855380
Background: Patients with chronic lung disease (CLD), such as asthma or chronic obstructive pulmonary disease, were expected to have an increased risk of clinical manifestations and severity of COVID-19. However,...
3.
Fernandez-de-Las-Penas C, Torres-Macho J, Ruiz-Ruigomez M, Arrieta-Ortubay E, Rodriguez-Rebollo C, Akasbi-Moltalvo M, et al.
J Med Virol
. 2024 May;
96(5):e29676.
PMID: 38747018
The SARS-CoV-2 VIrus PERsistence (VIPER) study investigated the presence of long-lasting SARS-CoV-2 RNA in plasma, stool, urine, and nasopharyngeal samples in COVID-19 survivors. The presence of SARS-CoV-2 RNA reverse transcription...
4.
Casas-Rojo J, Anton-Santos J, Millan-Nunez-Cortes J, Gomez-Huelgas R, Ramos-Rincon J, Rubio-Rivas M, et al.
Sci Rep
. 2023 Oct;
13(1):17731.
PMID: 37853011
In 2020, the COVID-19 pandemic followed a two-wave pattern in most countries. Hospital admission for COVID-19 in one wave or another could have affected mortality, especially among the older persons....
5.
Navas Alcantara M, Montero Rivas L, Guisado Espartero M, Rubio-Rivas M, Ayuso Garcia B, Moreno Martinez F, et al.
Med Clin (Engl Ed)
. 2022 Aug;
159(5):214-223.
PMID: 35935808
Introduction: Smoking can play a key role in SARS-CoV-2 infection and in the course of the disease. Previous studies have conflicting or inconclusive results on the prevalence of smoking and...
6.
Ramos-Rincon J, Lopez-Carmona M, Cobos-Palacios L, Lopez-Sampalo A, Rubio-Rivas M, Martin-Escalante M, et al.
J Clin Med
. 2022 Jul;
11(13).
PMID: 35807058
(1) Background: Large cohort studies of patients with COVID-19 treated with remdesivir have reported improved clinical outcomes, but data on older patients are scarce. Objective: This work aims to assess...
7.
Rubio-Rivas M, Mora-Lujan J, Formiga F, Corrales Gonzalez M, Garcia Andreu M, Moreno-Torres V, et al.
Intern Emerg Med
. 2022 Mar;
17(4):1115-1127.
PMID: 35235131
Uncontrolled inflammation following COVID-19 infection is an important characteristic of the most seriously ill patients. The present study aims to describe the clusters of inflammation in COVID-19 and to analyze...
8.
Calderon-Parra J, Cuervas-Mons V, Moreno-Torres V, Rubio-Rivas M, Agudo-de Blas P, Pinilla-Llorente B, et al.
Int J Infect Dis
. 2021 Dec;
116:51-58.
PMID: 34971824
Objectives: The aim of this study was to analyze whether subgroups of immunosuppressive (IS) medications conferred different outcomes in COVID-19. Methods: The study involved a multicenter retrospective cohort of consecutive...
9.
Navas Alcantara M, Montero Rivas L, Guisado Espartero M, Rubio-Rivas M, Ayuso Garcia B, Moreno Martinez F, et al.
Med Clin (Barc)
. 2021 Dec;
159(5):214-223.
PMID: 34895891
Introduction: Smoking can play a key role in SARS-CoV-2 infection and in the course of the disease. Previous studies have conflicting or inconclusive results on the prevalence of smoking and...
10.
Paredes-Ruiz D, Gomez-Cuervo C, Gomez-Martin C, Sanchez-Guerrero A, Gonzalez-Olmedo J, Lopez-Lopez F, et al.
J Thromb Thrombolysis
. 2021 Apr;
53(2):471-478.
PMID: 33890200
An increased risk of venous thromboembolism (VTE) in hospitalized patients with COVID-19 has been reported. We aimed to describe the incidence rate of VTE on patients with non-hematological cancer who...